TD Cowen Raises PT on Genpact Limited (G); Maintains 'Buy' Rating

Genpact Limited (NYSE:G) is one of the 10 Best Cheap Stocks to Buy According to Billionaire Ray Dalio. Bridgewater Associates holds over $35 million worth of shares of G, which represents 0.16% of its portfolio.

On June 27, 2025, TD Cowen announced its decision to raise its price target on Genpact Limited (NYSE:G) from $53 to $55, while maintaining a ‘Buy’ rating. The analyst attributed this to optimistic commentary on Q2 and full-year 2025 during the company’s Investor Day that focused on AI strategy. The analyst further highlighted the company’s medium-term outlook, which is expected to exceed the Street’s FY2026 revenue and earnings estimates. Meanwhile, the company announced a quarterly dividend of $0.17 per share on June 6, 2025, while also finalizing its acquisition of XponentL Data to strengthen its AI capabilities on June 5, 2025.

Operating across sectors like finance, healthcare, consumer goods, and manufacturing, Genpact Limited (NYSE:G) provides business process outsourcing and IT services. It operates across North America, Europe, Asia, and Latin America. It is among the list of cheap stocks to buy.

While we acknowledge the potential of G as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

Disclosure: None.